Join UsContact Us|中EN
RareStone Introduction
RareStone Group is dedicated to building the first rare disease ecosystem in the Greater China, to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable service supports.
  • 琅钰集团
  • 琅钰集团
  • Citrine Medicine is a pharmaceutical company and focused on providing effective and affordable therapeutic solutions to rare disease patients in the Greater China. Citrine Medicine currently focuses on 4 therapeutic areas: neurology, endocrinology, liver, kidney & metabolic diseases, and rare oncology. Citrine already has two assets WAKIX® & Alkindi® in pre-NDA stage for rare diseases in neurology and endocrinology, respectively.
  • Zircon Health is developing the first ecosystem to serve patients and families impacted by rare diseases in China. Zircon will focus on directly engaging patients and patient organizations to help rare disease community in China to improve access to knowledge, access to care, access to payment, access to non-pharma solutions.